Brompheniramine
Brompheniramine is a first generation H1 receptor antagonist antihistamine and is indicated for use in allergic rhinitis, urticarial, urticarial transfusion reaction, and vasomotor rhinitis.
Antihistamines are compounds that act as antagonists to the body’s release of histamine. Histamine is synthesized in the body by the decarboxylation of the amino acid histidine.
The prominent therapeutic use of antihistamines is to mitigate the hypersensitivity reactions that are caused by histamine; the reddening of the eyes, swelling, and itching are all suppressed by these antihistamines.
Brompheniramine is well absorbed after an oral dose and is highly bound to protein. The duration of the physiological action is usually between 4-6 hours. Brompheniramine is metabolized via the cytochrome 450 enzyme system.
General therapeutic concentrations of these drugs in the blood range from 0.5 to 5 mg/mL.
- Therapeutic monitoring
- Postoperative analgesia
- Toxicity assessment
- Patient Compliance
General Therapeutic Level: 0.5 - 5 mg/mL
Toxic level: Varies by antihistamine compound
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values can vary based on the particular method of analysis that is used for detection by a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.
Urine
Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.
Stability
- Ambient: 5 days
- Refrigeration: 7 days
- Frozen: 30 days
Serum
Serum specimens that are collected in a non-gel red top tube are the preferred specimens of choice. Plasma specimens are acceptable if drawn in a heparin (green top) tube. Specimens should be spun and the serum or plasma separated and refrigerated.
Stability
- Refrigeration: 7 days
- Frozen: 30 days
- Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Littleton, MA: PSG Publishing Co.; 1987.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Forster City, CA: Biomedical Publications; 2002.
- Gupta RN. Review: drug level monitoring: sedative hypnotics. J Chromatography. 1985;340:139-72.
- Levine B (ed). Principles of Forensic Toxicology, 4th ed. Washington DC: AACC Press. Chapter 25, Antihistamines pp. 435-440; 2013.
- Brunton LL, Chabner B, Knollman B, eds. Goodman and Gilmans’ the pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill; 2010.
- Cooper FJ, Logan BK. Drugs and human performance fact sheets. Washington, DC: National Highway Traffic Safety Administration, U.S. Department of Transportation. DOT HS 809 725; 2004.
- Katzung BG, Masters S, Trevor AK (eds). Basic and clinical pharmacology, 12th ed. New York: McGraw-Hill; 2011.
- Stout PR, Farrell LJ. Opioids – Effects on human performance and behavior. Forensic Sci Rev. 2002;15:29-59.
- Wu A (ed). Tietz, clinical guide to laboratory test, 4th ed. Philadelphia: WB Saunders; 2006.